25.01.2017 • Topics

Azelis to Distribute Angus’ Portfolio of Nitroalkanes in Europe

Angus Chemical Company announced an arrangement with Azelis as part of its new distribution strategy for the company’s complete portfolio of nitroalkanes and their derivatives sold in Europe. The Belgian specialty chemicals distributor has been appointed as a distribution partner, effective Jan. 1, 2017. The partnership includes the biotechnology market on a pan-European basis (including Turkey, and excluding Finland, Lithuania, Latvia and Estonia until April 1, 2017) and paints, coatings and other industrial markets for France, Belgium, The Netherlands and Luxembourg.

“We look forward to the technical expertise and logistics capabilities the Azelis team brings to delivering the products and support our Life Sciences customers need on a pan-European basis, while providing a more focused geographical approach for customers in specific paints and coatings, and other industrial markets,” said Liam Doherty, business vice president, EMEA and India.

Matthew Dickman, Azelis’ market segment director Pharma, added: “Angus and Azelis Pharma share the same focus on delivering market-specific solutions and expertise. The partnership will enable both parties to focus on providing the highest level of technical, logistical and customer service support to the growing customer base across Europe and Turkey. We are delighted to partner with Angus for this strategic business, utilising the extensive network of Azelis and the unrivalled technical and product experience of Angus to drive growth and innovation for our customers.”

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read